Survival curve estimation for informatively coarsened discrete event-time data

Statistics in Medicine

Volumn 26, Issue 10, 2007, Pages 2184-2202

  Shardell, Michelle ^a   Scharfstein, Daniel O ^b   Bozzette, Samuel A ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Coarsened at random; Informative censoring; Interval censoring; Sensitivity analysis; Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ANALYTICAL ERROR; ANALYTICAL PARAMETERS; ARTICLE; BAYES THEOREM; BIOSTATISTICS; CONTROLLED STUDY; DATA ANALYSIS; FREQUENCY ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEDICAL EXPERT; SENSITIVITY ANALYSIS; SIMULATION;

BAYES THEOREM; DATA INTERPRETATION, STATISTICAL; HIV INFECTIONS; HUMANS; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 34247641676     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2697     Document Type: Article

References (37)

1. Lindsey JC, Ryan LM. Methods for interval-censored data (Corr: 1999V18 p890). Statistics in Medicine 1998; 17:219-238.
2. Heitjan DF, Rubin DB. Ignorability and coarse data. The Annals of Statistics 1991; 19:2244-2253.
3. Heitjan DF. Ignorability and coarse data: some biomedical examples. Biometrics 1993; 49:1099-1109.
4. Heitjan DF. Ignorability in general incomplete-data models. Biometrika 1994; 81:701-708.
5. Peto R. Experimental survival curves for interval-censored data. Applied Statistics 1973; 22:86-91.
6. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. Journal of the Royal Statistical Society, Series B 1976; 38:290-295.
7. Gentleman R, Geyer CJ. Maximum likelihood for interval censored data: consistency and computation. Biometrika 1994; 81:618-623.
8. Gill RD, van der Laan MJ, Robins JM. Coarsening at random: characterizations, conjectures and counter-examples. In State of the Art in Survival Analysis, Lin DY, Fleming TR (eds). Springer: New York, 1997; 255-294.
9. Betensky RA, Finkelstein DM. Testing for dependence between failure time and visit compliance with interval-censored data. Biometrics 2002; 58:58-63.
10. Finkelstein DM, Goggins WB, Schoenfeld DA. Analysis of failure time data with dependent interval censoring. Biometrics 2002; 58:298-304.
11. Hughes JP, Richardson BA. Analysis of a randomized trial to prevent vertical transmission of HIV-1. Journal of the American Statistical Association 2000; 95:1032-1043.
12. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. Journal of the Royal Statistical Society, Series B 1977; 39:1-22.
13. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53:457-481.
14. Barker FG, Jannetta PJ, Amesh R, Babu P, Pomonis S, Bissonette DJ, Jho HD. Long-term outcome after operation for trigerminal neuralgia in patients with posterior fossa tumors. Journal of Neurosurgery 1996; 84:313-825.
15. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatric Pulmonology 1998; 26:81-88.
16. The Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. The Journal of Infectious Diseases 2004; 189: 2154-2166.
17. Learner EE. Specification Searches. Wiley: New York, 1978.
18. Greenland S. Probability logic and probabilistic induction. Epidemiology 1998; 9:322-332.
19. Kadane JB. Subjective Bayesian analysis for surveys with missing data. The Statistician 1993; 42:415-426.
20. Matthews RAJ. Facts versus factions: the use and abuse of subjectivity in scientific research. In Rethinking Risk and the Precautionary Principle, Morris J (ed). Oxford: London, 2000; 247-282.
21. Rotnitzky A, Scharfstein D, Su TL, Robins J. Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring. Biometrics 2001; 57:103-113.
22. Scharfstein DO, Robins JM, Eddings W, Rotnitzky A. Inference in randomized studies with informative censoring and discrete time-to-event endpoints. Biometrics 2001; 57:404-413.
23. Scharfstein DO, Daniels M, Robins JM. Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing data. Biostatistics 2003; 4:495-512.
24. Greenland S. Multiple-bias modeling for analysis of observational data (with Discussion). Journal of the Royal Statistical Society, Series A 2005; 168:267-308.
25. Geman S, Geman D. Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images. IEEE Transactions in Pattern Analysis and Machine Intelligence 1984; 6:721-741.
26. Tanner MA, Wong WH. The calculation of posterior distributions by data augmentation. Journal of the American Statistical Association 1987; 82:528-540.
27. Calle ML, Gomez G. Nonparametric Bayesian estimation from interval-censored data using Monte Carlo methods. Journal of Statistical Planning and Inference 2001; 96:73-87.
28. Rubin DB. Inference and missing data. Biometrika 1976; 63:581-592.
29. Barndorff-Nielsen OE, Cox DR. Asymptotic Techniques for Use in Statistics. Chapman & Hall: London, 1989.
30. Birmingham J, Rotnitzky A, Fitzmaurice GM. Pattern-mixture and selection models for analysing longitudinal data with monotone missing patterns. Journal of the Royal Statistical Society, Series B 2003; 65:275-297.
31. Louis TA. Finding the observed information matrix when using the EM algorithm. Journal of the Royal Statistical Society, Series B 1982; 44:226-233.
32. Hastings WK. Monte Carlo sampling methods using Markov chains and their applications. Biometrika 1970; 57:97-109.
33. Betensky RA, Finkelstein DM. A non-parametric maximum likelihood estimator for bivariate interval censored data. Statistics in Medicine 1999; 18:3089-3100.
34. Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Philips L, Craven D, van der Horst C, Feinberg J. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. New England Journal of Medicine 1995; 332:693-699.
35. Cowles KP, Carlin BP. Markov chain Monte Carlo convergence diagnostics: a comparative review. Journal of the American Statistical Association 1996; 91:883-904.
36. Meyer M, Booker J. Eliciting and Analyzing Expert Judgement: A Practical Guide. Academic Press: New York, 1991.
37. Fletcher R. Practical Methods of Optimization. Wiley: New York, 1987.